We are live on ! Find out more
CFO

CVA Family Office Portfolio holdings

AUM $1.1B
1-Year Est. Return 26.6%
This Fund
S&P 500
This Quarter Est. Return
+6.63%
1 Year Est. Return
+26.6%
3 Year Est. Return
+71.56%
5 Year Est. Return
+71.4%
10 Year Est. Return
–
AUM
$616M
AUM Growth
+$60.5M
Cap. Flow
+$24.7M
Cap. Flow %
4.01%
Top 10 Hldgs %
36.97%
Holding
1,370
New
95
Increased
483
Reduced
247
Closed
104

Top Buys

Rank Stock Value
1
BBJP icon
JPMorgan BetaBuilders Japan ETF
BBJP
+$4.14M
2
DFUS
Dimensional US Equity ETF
DFUS
+$2.75M
3
DFAC icon
Dimensional US Core Equity 2 ETF
DFAC
+$2.21M
4
SCHD icon
Schwab US Dividend Equity ETF
SCHD
+$1.89M
5
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$1.84M

Top Sells

Rank Stock Value
1
FNDE icon
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
+$1.12M
2
FNDF icon
Schwab Fundamental International Large Company Index ETF
FNDF
+$763K
3
AVUS icon
Avantis US Equity ETF
AVUS
+$537K
4
DOG
ProShares Short Dow30
DOG
+$435K
5
PRFT
Perficient Inc
PRFT
+$424K

Sector Composition

Rank Sector Weight
1 Technology 8.03%
2 Financials 3.72%
3 Healthcare 2.9%
4 Consumer Staples 2.36%
5 Industrials 2.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OZK icon
1126
Bank OZK
OZK
$5.61B
$688 ﹤0.01%
16
– –
SLVM icon
1127
Sylvamo
SLVM
$1.63B
$687 ﹤0.01%
8
– –
TWST icon
1128
Twist Bioscience
TWST
$7.25B
$678 ﹤0.01%
15
– –
HCP
1129
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
$677 ﹤0.01%
20
– –
HLNE icon
1130
Hamilton Lane
HLNE
$5.57B
$674 ﹤0.01%
4
– –
FTDR icon
1131
Frontdoor
FTDR
$6.26B
$672 ﹤0.01%
+14
New +$607
RXO icon
1132
RXO
RXO
$3.58B
$672 ﹤0.01%
24
– –
AGIO icon
1133
Agios Pharmaceuticals
AGIO
$1.93B
$666 ﹤0.01%
15
– –
THC icon
1134
Tenet Healthcare
THC
$21.1B
$665 ﹤0.01%
+4
New +$605
MOD icon
1135
Modine Manufacturing
MOD
$10.4B
$664 ﹤0.01%
+5
New +$553
AGYS icon
1136
Agilysys
AGYS
$3.06B
$654 ﹤0.01%
6
– –
NMRK icon
1137
Newmark Group
NMRK
$2.63B
$652 ﹤0.01%
+42
New +$545
CWEN icon
1138
Clearway Energy Class C
CWEN
$6.7B
$644 ﹤0.01%
21
– –
RIVN icon
1139
Rivian
RIVN
$23.2B
$640 ﹤0.01%
57
-6
-10% -$86
BRSL
1140
Brightstar Lottery PLC
BRSL
$2.03B
$639 ﹤0.01%
30
+7
+30% +$150
NTRA icon
1141
Natera
NTRA
$46.4B
$635 ﹤0.01%
5
– –
INSP icon
1142
Inspire Medical Systems
INSP
$1.74B
$633 ﹤0.01%
+3
New +$521
U icon
1143
Unity
U
$18.9B
$633 ﹤0.01%
+28
New +$484
VKTX icon
1144
Viking Therapeutics
VKTX
$4B
$633 ﹤0.01%
+10
New +$587
ADNT icon
1145
Adient
ADNT
$1.5B
$632 ﹤0.01%
28
+10
+56% +$229
PTCT icon
1146
PTC Therapeutics
PTCT
$6.12B
$631 ﹤0.01%
17
– –
OLED icon
1147
Universal Display
OLED
$4.19B
$630 ﹤0.01%
3
– –
RYTM icon
1148
Rhythm Pharmaceuticals
RYTM
$7.96B
$629 ﹤0.01%
12
– –
KNF icon
1149
Knife River
KNF
$3.79B
$626 ﹤0.01%
+7
New +$547
BRO icon
1150
Brown & Brown
BRO
$23.9B
$622 ﹤0.01%
6
-12
-67% -$1.19K
44 45
46
47 48

Similar funds

YL
YCG LLC Austin, Texas $1.1B AUM 4.87% 1-Year Est. Return
SL
Sentinus LLC Oak Brook, Illinois $1.11B AUM 17.13% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
JTWM
Jackson Thornton Wealth Management Montgomery, Alabama $1.11B AUM 22.53% 1-Year Est. Return
RWM
RKL Wealth Management Lancaster, Pennsylvania $1.11B AUM 18.99% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
EIA
Emerald Investment Advisers Leola, Pennsylvania $1.11B AUM

CVA Family Office's Q3 2024 Portfolio in Review

As of Q3 2024, CVA Family Office held 1,370 positions worth $616M, up 11% from $556M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

CVA Family Office deployed $24.7M of net new capital in Q3 2024, opening 95 new positions and adding to 483 existing holdings. Its largest new stake was WisdomTree Floating Rate Treasury Fund: 28,527 shares worth $1.43M.

By sector, the portfolio is most concentrated in Technology at 8% of assets, down from 8.5% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Schwab Fundamental Emerging Markets Large Company Index ETF, an estimated $1.12M trimmed.

  • CVA Family Office's largest Q3 2024 buy was WisdomTree Floating Rate Treasury Fund: 28,527 shares worth $1.43M.
  • CVA Family Office added most to JPMorgan BetaBuilders Japan ETF in Q3 2024, an estimated $4.14M increase.
  • CVA Family Office's biggest Q3 2024 reduction was Schwab Fundamental Emerging Markets Large Company Index ETF, cutting an estimated $1.12M.
  • CVA Family Office fully exited ProShares Short Dow30 in Q3 2024, selling an estimated $435K.
  • CVA Family Office's ten largest holdings make up 37% of its $616M portfolio in Q3 2024.
  • CVA Family Office opened 95 new positions and closed 104 in Q3 2024.
  • CVA Family Office's portfolio value rose 11% quarter-over-quarter to $616M.

Based on CVA Family Office's 13F filing for Q3 2024, filed 10 Oct 2024.